Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
This white paper discusses the benefits of a combined safety services and technology model for drug sponsors to meet evolving drug safety and pharmacovigilance needs, and highlights the advantages of working with a vendor that leverages this model. It also introduces IQVIA's Integrated Safety Model as a flexible, globally scalable solution.
Download and learn how IQVIA can benefit your safety service and technology needs.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.